Sentences with phrase «in nuclear imaging»

Dr. Richard Fleming, an accomplished nuclear cardiologist, enrolled 26 people into a comprehensive study of the effects of diet on cardiac function using the latest in nuclear imaging technology — so - called SPECT scans, enabling him to actually directly measure the blood flow within the coronary arteries.

SNMMI NET Roadshow Advances in Nuclear Imaging and Therapy for Neuroendocrine Tumors August 24, 2017 Grand America Hotel Seattle, WA

Not exact matches

Richard Hargreaves, executive director of imaging at Merck Research Laboratories, says, «Nuclear imaging using radiotracers gives the opportunity to put your arms around proof - of - concept very early in a drug discovery and development program by focusing the selection of doses to study on those proven to deliver enough drug to the target therapeutic sites.»

Scientists are taking medical imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).

Direct positron imaging is a nuclear medicine technique that allows researchers to gain physiological information from radiolabeled imaging agents that bind to targets in the body, which are then imaged with a specialized detector.

The former is ideal for soft - tissue contrast, and the latter has extremely fine imaging resolution due to a revolution in the technology called dynamic nuclear spin polarization, which is used to track minute biochemistry in the body — such as the transition of the naturally occurring chemical pyruvate to lactate.

In a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyIn a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyin the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyin the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyin the body).

In a related editor's note, JAMA Internal Medicine Editor - in - Chief Rita F. Redberg, M.D., M.Sc., writes: «These findings suggest that the current practice of performing a stress test on low - risk patients in the ED is unnecessary and prolongs the length of stay in EDs as well as increases unnecessary medical imaging, with significant associated radiation risk for tests that include nuclear imaginIn a related editor's note, JAMA Internal Medicine Editor - in - Chief Rita F. Redberg, M.D., M.Sc., writes: «These findings suggest that the current practice of performing a stress test on low - risk patients in the ED is unnecessary and prolongs the length of stay in EDs as well as increases unnecessary medical imaging, with significant associated radiation risk for tests that include nuclear imaginin - Chief Rita F. Redberg, M.D., M.Sc., writes: «These findings suggest that the current practice of performing a stress test on low - risk patients in the ED is unnecessary and prolongs the length of stay in EDs as well as increases unnecessary medical imaging, with significant associated radiation risk for tests that include nuclear imaginin the ED is unnecessary and prolongs the length of stay in EDs as well as increases unnecessary medical imaging, with significant associated radiation risk for tests that include nuclear imaginin EDs as well as increases unnecessary medical imaging, with significant associated radiation risk for tests that include nuclear imaging.

A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).

Unfortunately, nature is not always willing to easily part with its secrets, forcing scientists to rely on sophisticated imaging technology — nuclear magnetic resonance (NMR) spectroscopy or mass spectrometry, for example — to decipher the molecular formula of newly discovered organic compounds so they can be replicated in the lab.

The test results were presented at the 2016 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in San Diego on June 13.

In particular, new developments in emission tomography, nuclear magnetic resonance imaging, and in vivo spectroscopy offer new horizons for medical research and clinical activitieIn particular, new developments in emission tomography, nuclear magnetic resonance imaging, and in vivo spectroscopy offer new horizons for medical research and clinical activitiein emission tomography, nuclear magnetic resonance imaging, and in vivo spectroscopy offer new horizons for medical research and clinical activitiein vivo spectroscopy offer new horizons for medical research and clinical activities.

Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in women with dense breasts and at higher risk for developing breast cancer.

Since his prediction, Alfvén waves have been associated with a variety of sources, including nuclear reactors, the gas cloud that envelops comets, laboratory experiments, medical MRI imaging and in the atmosphere of our nearest star — the Sun.

While these imaging procedures, including fluoroscopically guided procedures such as cardiac catheterization, computed tomography scans, and nuclear medicine studies, are critical for accurate diagnosis and intervention, ionizing radiation in high doses can be harmful.

The increase in medical radiation exposure (from 0.53 mSv to 3.0 mSv) stemmed primarily from a rise in the use of computer tomography (CT) scans (which use x-rays to create cross sectional images of inside the body to spot tumors, clogged arteries, among other things), and nuclear imaging tests, which involve injecting radioactive chemicals into the bloodstream that can be picked up by special instruments and used to create images of the body's inner structures.

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon - 11 labeled sarcosine (11C - sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancerIn the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon - 11 labeled sarcosine (11C - sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancerin the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon - 11 labeled sarcosine (11C - sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancerin monitoring other cancers.

Baltimore, Md. (Embargoed until 12:30 pm EDT on Monday, June 8)-- A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).

Having grown to know the analytical technique of nuclear magnetic resonance as NMR, I was intrigued to discover that in medical imaging it now goes under the name of MRI, which stands for magnetic resonance imaging.

A recent innovation in breast cancer biomarkers seeks the HER3 receptor instead, which could mean more comprehensive breast cancer imaging and potential treatments, say experts presenting data during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Mimaging and potential treatments, say experts presenting data during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual MImaging's 2014 Annual Meeting.

SNMMI - TS's Mission: The section is dedicated to improving human health by advancing technology and professionals in nuclear medicine and molecular imaging.

The purpose of the program is to provide experience and training in nuclear medicine / molecular imaging modalities in the areas of cardiology, neurology, and oncology.

«It symbolizes distinguished service to SNMMI as well as exceptional achievement in the field of nuclear medicine and molecular imaging.»

The Congress, Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and Johns Hopkins Medicine, welcomed physicians, chemists, physicists, technologists, and all scientists and clinicians interested in translational research and current state - of - the - art molecular imaging using Ga - 68 PET radiopharmaceuticals and radionuclide tImaging (SNMMI) and Johns Hopkins Medicine, welcomed physicians, chemists, physicists, technologists, and all scientists and clinicians interested in translational research and current state - of - the - art molecular imaging using Ga - 68 PET radiopharmaceuticals and radionuclide timaging using Ga - 68 PET radiopharmaceuticals and radionuclide therapy.

This multimodal study shows significant correlation between increased tau and decreased metabolic activity in the brain — a clear sign of neurodegeneration — reveal researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

With critical developments in functional imaging and the methods and practice of nuclear medicine, technologists are in need of new skill sets and educational models to advance their career.

San Diego, Calif. (Embargoed unil 10 a.m. PT, June 13, 2016)- The Society of Nuclear Medicine and Molecular Imaging announced the creation of an SNMMI Fellowship recognizing distinguished service to SNMMI as well as exceptional achievement in the field of nuclear medicine and molecular iNuclear Medicine and Molecular Imaging announced the creation of an SNMMI Fellowship recognizing distinguished service to SNMMI as well as exceptional achievement in the field of nuclear medicine and molecular iImaging announced the creation of an SNMMI Fellowship recognizing distinguished service to SNMMI as well as exceptional achievement in the field of nuclear medicine and molecular inuclear medicine and molecular imagingimaging.

As part of its continuing commitment to growing the practice of nuclear medicine and molecular imaging and therapy worldwide, SNMMI leadership works diligently to develop strategic alliances with key regional nuclear medicine organizations to assist these groups in expanding the scope and quality of nuclear medicine outside the United States.

Each year, SNMMI chooses an image that exemplifies the most promising advances in the field of nuclear medicine and molecular imaging.

Selection of SNMMI Fellows will be based on documented excellence in volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation; educational efforts in nuclear medicine and molecular imaging; or clinical practice of nuclear medicine and molecular imaging.

SNMMI launched a new fellowship program at the Sunday plenary to recognize distinguished service to SNMMI, as well as exceptional achievement in the field of nuclear medicine and molecular imaging.

This award is funded through an endowed gift given to the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) by the Dr. Michael J. Welch Foundation in memoriam of Professor Michael J. Welch, PhD, who passed away in 2012.

Over the years, multiple pathways have been developed to begin a career in imaging and specifically in nuclear medicine technology including:

The scope of practice in nuclear medicine technology includes, but is not limited to, the following areas and responsibilities: Patient Care; Quality Control; Diagnostic Procedures; Radiopharmaceuticals; In - Vivo Diagnostic Testing; In - Vitro Diagnostic Testing; Transmission Imaging; Radionuclide Therapy and Radiation Safetin nuclear medicine technology includes, but is not limited to, the following areas and responsibilities: Patient Care; Quality Control; Diagnostic Procedures; Radiopharmaceuticals; In - Vivo Diagnostic Testing; In - Vitro Diagnostic Testing; Transmission Imaging; Radionuclide Therapy and Radiation SafetIn - Vivo Diagnostic Testing; In - Vitro Diagnostic Testing; Transmission Imaging; Radionuclide Therapy and Radiation SafetIn - Vitro Diagnostic Testing; Transmission Imaging; Radionuclide Therapy and Radiation Safety.

Reston, Va. (June 15, 2016)-- More than 5,700 physicians, technologists, scientists and exhibitors gathered at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2016 Annual Meeting, held June 11 - 15 in San Diego, Calif..

Vivid Description: The Technologist Section of the SNMMI has elevated the importance and value of nuclear medicine and molecular imaging in contributing to successful patient outcomes.

Further to my research and clinical activities, as President of the World Federation of Nuclear Medicine and Biology, the peak global Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA aNuclear Medicine and Biology, the peak global Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA aNuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA anuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA and WHO.

These garnets, when doped with various elements, are used as detectors of X-rays and gamma - rays in a wide range of applications including border security, nuclear safeguards, medical imaging, materials diagnostics and astronomy.

This EU - funded programme links groups working on the response of stem cells to low doses of ionising radiation, such as found in medical imaging or nuclear accidents.

SNMMI continues to stay actively involved in several jointly sponsored educational programs and educational outreach activities with regional nuclear medicine and molecular imaging and therapy organizations around the world; both in their home countries, and during SNMMI's Annual Meeting.

In nuclear medicine imaging, the radiopharmaceuticals are detected by special types of cameras that work with computers to provide very precise pictures of the area of the body being imaged.

Specifically, I am leading a Project focusing on Nitrogen - Vacancy centers in nanostructured diamond as a means to hyperpolarize nuclear spins for the production of hyperpolarized agents for imaging of cells and tissues in living organisms.

IDKD Faculty are leading experts in medical imaging, including interventional radiology, nuclear medicine, pediatric radiology, and breast imaging (mammography).

Clinical Trials Research and Billing First in Human / Early Phase PET in Oncology Case - Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine Therapy for Hyperthyroidism: The State of the Art Spondylodiscitis: Role of Imaging for Diagnosis and Monitoring Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment Models and Value - Based Health Care: Nuts and Bolts Maximal Tolerated Activity of Radioactive Iodine for Metastatic Thyroid Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging of Lung Inflammation Standardization of Advanced PET / SPECT Data Acquisition and Analysis Thyroid Cancer Management: Novel Therapeutics and Management Options Targeting Radionuclide Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?

Nuclear medicine is also different from other imaging procedures in that it determines the presence of disease based on biological changes in tissue rather than changes in anatomy.

Hosted by the SNMMI 2018 Annual Meeting Exhibitors SNMMI's Exhibit / Poster Hall is always packed with more than 160 companies representing the latest innovations in nuclear medicine and molecular imaging products and services.

Topics covered include embryonic stem cells, pluripotency, germline stem cells, tissue - specific stem cells, stem cell differentiation, epigenetics, stem cell genomics and systems biology, genome reprogramming, cancer stem cells, stem cell niches, stem - cell - based disease models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging of stem cells, therapeutic applications, regenerative medicine, clinical and translational insights, stem cell research policies, ethical issues, and technical or resource - based innovations.

Nuclear medicine — a vital component of the rapidly emerging field of molecular imaging — is a medical specialty that uses small amounts of radioactive materials bound to special compounds (radiopharmaceuticals) in combination with imaging instrumentation that examine molecular processes in the body to detect and evaluate disease, such as brain disorders, heart disease and cancer.

Available to physicians, scientists or pharmacists possessing an advanced degree who have presented credentials indicating their professional activity, either, medical, paramedical, investigational or educational in the scientific or clinical disciplines of molecular imaging or nuclear medicine.

The SNMMI Bradley - Alavi Student Fellowships are designed to stimulate students» interest in molecular imaging / nuclear medicine by supporting their full - time participation in clinical and basic research activities for three months (or less).